First Wave BioPharma Inc

FWBI
2,60
-0,19 (-6,81%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202413:00GLOBEFirst Wave BioPharma Announces Invited Paper for Special..
17/4/202413:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
15/4/202413:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Participate in..
18/3/202412:00GLOBEFirst Wave BioPharma Announces Two Abstracts on Celiac..
14/3/202411:00GLOBEFirst Wave BioPharma Announces Completion of Business..
05/3/202423:26EDGAR2Form 8-K - Current report
05/3/202413:00GLOBEFirst Wave BioPharma to Participate In ‘Fireside Chat’ at..
04/3/202423:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202414:00GLOBEFirst Wave BioPharma, Inc. to Raise Approximately $4.0..
13/2/202413:00GLOBEFirst Wave BioPharma CEO to Present at the BIO CEO &..
23/1/202413:00GLOBEFirst Wave BioPharma to Present at the DealFlow MicroCap..
18/1/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
17/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202413:00GLOBEFirst Wave BioPharma CEO to Present at the Sequire Investor..
08/1/202423:14EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202414:22EDGAR2Form 8-K - Current report
04/1/202412:00GLOBEFirst Wave BioPharma Chairman and CEO Issues Letter to..
04/1/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202318:21EDGAR2Form RW - Registration Withdrawal Request
27/12/202323:23EDGAR2Form 8-K - Current report
27/12/202317:55GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
27/12/202314:04EDGAR2Form S-1/A - General form for registration of securities..
27/12/202312:15EDGAR2Form 8-K - Current report
27/12/202312:00GLOBEFirst Wave BioPharma Announces Streamlining of Clinical..
18/12/202313:00EDGAR2Form 8-K - Current report
18/12/202312:00GLOBEFirst Wave BioPharma Announces Entry into Term Sheet for..
16/12/202303:48EDGAR2Form S-1/A - General form for registration of securities..
14/12/202315:15EDGAR2Form 8-K - Current report
14/12/202315:15GLOBEFirst Wave BioPharma Announces 1-for-20 Reverse Stock Split..
06/12/202313:00GLOBEFirst Wave BioPharma to Participate in BIO Partnering @JPM..
05/12/202313:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Moderate Panel..
13/11/202322:20EDGAR2Form DEF 14A - Other definitive proxy statements
13/11/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:51EDGAR2Form S-1 - General form for registration of securities under..
31/10/202322:24EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
31/10/202322:21EDGAR2Form 8-K - Current report
12/10/202323:06EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202322:06EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202313:00GLOBEDate and Time Announced for First Wave BioPharma CEO James..
06/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202313:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
02/10/202315:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/9/202315:38EDGAR2Form S-3 - Registration statement under Securities Act of..
15/9/202322:05EDGAR2Form 8-K - Current report
15/9/202314:45GLOBEFirst Wave BioPharma To Present at the BIO Investor Forum
14/9/202316:43GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
14/9/202312:19EDGAR2Form 8-K - Current report
Apertura: 2,78 Min: 2,59 Max: 2,9872
Chiusura: 2,79

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network